USTEKINUMAB Adverse Event: Malignant melanoma in situ
USTEKINUMAB Adverse Event: Malignant melanoma in situ is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: USTEKINUMAB; Product category: Drug; Primary reaction: Malignant melanoma in situ.
| Primary drug | USTEKINUMAB |
|---|---|
| Product category | Drug |
| Primary reaction | Malignant melanoma in situ |
| All reactions | Malignant melanoma in situ |
| Seriousness | Serious |
| Patient outcome | Recovered/Resolved |
| Patient sex | Male |
| All drugs reported | USTEKINUMAB |
| Reporter country | US |
| Reporter type | 3 |
| Report date | 20140313 |
| Report ID | 10007196 |
$299/mo
Try FDATracker →